Results of surgery for toxic multinodular goiter

• Published in: Surgery today (Tokyo, Japan) Vol. 35; no. 11; pp. 901 - 906
• Main Authors: Ríos, Antonio, Rodríguez, José M, Balsalobre, María D, Torregrosa, Nuria M, Tebar, Francisco J, Parrilla, Pascual
• Format: Journal Article
• Language: English
• Published: Japan 01-11-2005
• Subjects: Female; Goiter, Nodular - complications; Goiter, Nodular - pathology; Goiter, Nodular - surgery; Humans; Hyperthyroidism - etiology; Male; Middle Aged; Recurrence; Thyroid Neoplasms - complications; Thyroidectomy - adverse effects
• ISSN: 0941-1291; 1436-2813
• DOI: 10.1007/s00595-004-3051-7

We analyzed the clinical and histological features of patients operated on for toxic multinodular goiter (TMG) to determine the clinical profile and evaluate the surgical results.
We reviewed 672 patients who underwent surgery for multinodular goiter (MG), 112 (17%) of whom had hyperthyroidism, and analyzed the epidemiological, clinical, and surgical variables.
The patients with TMG tended to be older than those with nontoxic MG, with a greater evolution time of the goiter and a higher rate of positive antithyroid antibodies. In the multivariate analysis, the only feature characteristic of TMG, as opposed to nontoxic MG, was the evolution time. Morbidity was 34%, representative of the fact that that most of the patients were seen before the establishment of our endocrine surgical unit. The hyperthyroid symptoms resolved in all patients, but 4 of 17 patients who underwent partial surgical resection showed signs of relapse within a follow-up period of 98 +/- 71 months.
TMG is characterized by a long evolution time and is most effectively treated by total thyroidectomy, which achieves complete remission from symptoms, without relapse, and is necessary if there is associated carcinoma. However, the incidence of complications may be high if this procedure is not carried out by surgeons with experience in endocrine surgery.